Among the 17 analysts tracking Aurora Cannabis, one recommends a buy, 12 recommend a hold, and four recommend a sell. The highest target price of $12.34 is 20.9 percent above the stock's current price, while the lowest target price of $3.60 is 64.7 percent below the stock's current price. ACB stock looks like a buy
Is Aurora Cannabis a good investment?
Therefore Aurora Cannabis is not a good investment because of the dependence of only one big Canadian market,very high valuation and lower growth prospects in the future. Hope this is helpful.
Is Aurora Cannabis the best pot Stock to buy now?
Investor Ideas #Potcasts 530, #Cannabis News and #Stocks on the Move ... related to how cannabis impacts the brain. We are now cataloguing the entire universe of effects for Cannabis 2.0 products.
Can Aurora Cannabis stock get as high as its peers?
Sure, Aurora’s past results were awful. That’s a big part of the reason why ACB stock is down almost 90% from its highs. Of course, the stock, even with a post-earnings pullback, has still rallied sharply from its lows. The Q2 report shows why it’s gone too far, and why it should have further to fall.
Is Aurora Cannabis a good buy?
Of the 16 analysts that follow Aurora Cannabis, 43.8% favored a “buy” rating. Also, 43.8% recommended a “hold” rating, and 12.5% favored a “sell” rating. Let’s look at analysts’ recommendations for Aurora’s peers:
See more
What is Aurora Cannabis stock symbol?
Aurora Cannabis is a Canadian stock, trading under the symbol ACB-T on the Toronto Stock Exchange (undefined). It is usually referred to as TSX:ACB...
Is Aurora Cannabis a buy or a sell?
In the last year, 1 stock analyst published opinions about ACB-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock....
Is Aurora Cannabis a good investment or a top pick?
Aurora Cannabis was never recommended as a Top Pick on Stockchase. Read the latest stock expertsratings for Aurora Cannabis.
Why is Aurora Cannabis stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should b...
Is Aurora Cannabis worth watching?
1 stock analyst on Stockchase covered Aurora Cannabis In the last year. It is a trending stock that is worth watching.
What is Aurora Cannabis stock price?
On 2022-06-08, Aurora Cannabis (ACB-T) stock closed at a price of $1.97.
Should I buy or sell Aurora Cannabis stock right now?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 2...
What is Aurora Cannabis' stock price forecast for 2022?
8 Wall Street research analysts have issued 1-year price objectives for Aurora Cannabis' stock. Their ACB stock forecasts range from $2.15 to $7.00...
How has Aurora Cannabis' stock price performed in 2022?
Aurora Cannabis' stock was trading at $5.41 at the start of the year. Since then, ACB stock has decreased by 74.1% and is now trading at $1.40. Vi...
When is Aurora Cannabis' next earnings date?
Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, September 26th 2022. View our earnings forecast for Au...
How were Aurora Cannabis' earnings last quarter?
Aurora Cannabis Inc. (NYSE:ACB) posted its quarterly earnings data on Wednesday, May, 12th. The company reported ($0.82) EPS for the quarter, missi...
When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?
Aurora Cannabis's stock reverse split before market open on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. Th...
Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the following people: Mr. Miguel Martin , CEO & Director (Age 50, Pay $1.66M) Mr. Glen Ibbott , Chief...
Who are some of Aurora Cannabis' key competitors?
Some companies that are related to Aurora Cannabis include Cronos Group (CRON) , Cresco Labs (CRLBF) , Sundial Growers (SNDL) , Ascend Wellness...
What other stocks do shareholders of Aurora Cannabis own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC) , Cronos Gro...
How much did Aurora Cannabis stock gain in 2021?
The Aurora Cannabis Inc. stock price gained 1.73% on the last trading day (Friday, 9th Jul 2021), rising from $8.10 to $8.24. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.11% from a day low at $8.03 to a day high of $8.28. The price has fallen in 7 of the last 10 days and is down by -11.87% for this period. Volume fell on the last day by -3 million shares and in total, 2 million shares were bought and sold for approximately $15.35 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
When is the buy signal for 2021?
A buy signal was issued from a pivot bottom point on Friday, July 16, 2021, and so far it has risen 0.57%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development.
When will Aurora Cannabis release its earnings?
Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, September 23rd 2021. View our earnings forecast for Aurora Cannabis.
When will Aurora Cannabis stock split?
Aurora Cannabis's stock reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.
Is Aurora Cannabis a sell?
Wall Street analysts have given Aurora Cannabis a " Sell" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five companies may be ...
About Aurora Cannabis
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide.
Headlines
Will Aurora Bounce Back? Analyst Explains Why The Stock Is A 'Long-Term Turnaround Story'
Aurora Cannabis (TSE:ACB) Frequently Asked Questions
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Aurora Cannabis stock.
What is Aurora Cannabis?
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
What is a strong weekly advance?
A strong weekly advance (especially when accompanied by increased volume) is a sought after metric for putting potential momentum stocks onto one's radar. Others will look for a pullback on the week as a good entry point, assuming the longer-term price changes (4 week, 12 weeks, etc.) are strong.
Does Zackstrade endorse or recommend investment strategies?
The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
The popular marijuana producer is coming off a disastrous fourth quarter
Aurora Cannabis ( ACB -3.86% ) released its fourth-quarter results on Sept. 22 and they were yet another disappointment, with the company reporting a loss of 1.9 billion Canadian dollars for the period as impairment charges of CA$1.8 billion weighed heavily on its financials.
Can Aurora reverse its fortunes?
One of the reasons investors may be a bit optimistic about the company's future is that it has a new CEO in place. In September, Aurora announced that Miguel Martin would be taking over as CEO from Michael Singer. Singer, who is executive chairman, assumed the position after the resignation of Terry Booth in February.
NASDAQ: ACB
With Martin in his new role, Aurora is already looking at a new focus: premium products, including vapes, which should help improve margins and overall profitability.
Will reaching positive adjusted EBITDA be enough to win back investors?
It's been a rough year for Aurora: Revenue in Q4 last year was CA$98.9 million, 37% higher than in this past period. And while a positive adjusted EBITDA number would definitely get investors excited that the company is making progress, let's not forget this is primarily a growth stock.
Aurora still isn't a buy
Investors need to be careful about buying shares of companies in the middle of transitions. There's never any guarantee how they'll go, except that typically, they're not smooth rides. And that means there could be some tough times still ahead for Aurora investors. The worst, unfortunately, may still be to come.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
Analyst price target for ACB
Based on 4 analyst s offering 12 month price targets for Aurora Cannabis Inc.
ACB earnings per share forecast
What is ACB 's earnings per share in the next 3 years based on estimates from 4 analyst s?
ACB revenue forecast
What is ACB 's revenue in the next 3 years based on estimates from 4 analyst s?
ACB revenue growth forecast
How is ACB forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
